✦ LIBER ✦

Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT

✍ Scribed by Ditschkowski, M; Haferlach, C; Schulte, C; Trenschel, R; Beelen, D W

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of lymphoma relapses after all

✍ W. Y. Au; A. K. W. Lie; L. L. P. Siu; E. C. Chan; G. C. Ooi; A. Y. H. Leung; R. 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 144 KB

Second Allogeneic Stem-Cell Transplantat

✍ Shimoni, Avichai; Shem-Tov, Noga; Volchek, Yulia; Yerushalmi, Ronit; Nagler, Arn 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Successful unrelated allogeneic stem cel

✍ Koch, M; Lang, P; Bader, P; Kreyenberg, H; Schumm, M; Scheel-Walter, H; Hochhaus 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Rapid engraftment of mast cells of donor

✍ Chen, T-Y; Chen, J-S; Huang, W-T; Su, W-C; Tsao, C-J 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 110 KB

Nilotinib and donor lymphocyte infusion

✍ Mario Tiribelli; Alessandra Sperotto; Anna Candoni; Erica Simeone; Silvia Buttig 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Imatinib Mesylate (Gleevec) in the Treat

✍ Keiji Sugimoto; Michiaki Mikoshiba; Kazuteru Ohashi; Hideki Akiyama; Hisashi Sak 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 82 KB